Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Analytical performance of the serum free light chain assay.

Briand PY, Decaux O, Caillon H, Grosbois B, Le Treut A, Guenet L.

Clin Chem Lab Med. 2010;48(1):73-9. doi: 10.1515/CCLM.2010.012.

PMID:
19929752
2.

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.

de Tayrac M, Etcheverry A, Aubry M, Saïkali S, Hamlat A, Quillien V, Le Treut A, Galibert MD, Mosser J.

Genes Chromosomes Cancer. 2009 Jan;48(1):55-68. doi: 10.1002/gcc.20618.

3.

Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.

Gandemer V, Rio AG, de Tayrac M, Sibut V, Mottier S, Ly Sunnaram B, Henry C, Monnier A, Berthou C, Le Gall E, Le Treut A, Schmitt C, Le Gall JY, Mosser J, Galibert MD.

BMC Genomics. 2007 Oct 23;8:385.

4.

Iron-related transcriptomic variations in CaCo-2 cells, an in vitro model of intestinal absorptive cells.

Chicault C, Toutain B, Monnier A, Aubry M, Fergelot P, Le Treut A, Galibert MD, Mosser J.

Physiol Genomics. 2006 Jun 16;26(1):55-67. Epub 2006 Apr 25.

5.

Redox active plasma iron in C282Y/C282Y hemochromatosis.

Le Lan C, Loréal O, Cohen T, Ropert M, Glickstein H, Lainé F, Pouchard M, Deugnier Y, Le Treut A, Breuer W, Cabantchik ZI, Brissot P.

Blood. 2005 Jun 1;105(11):4527-31. Epub 2005 Jan 25.

6.

[A severely disturbed lipid profile].

Mignard S, Calon E, Hespel JP, Le Treut A.

Ann Biol Clin (Paris). 2004 May-Jun;62(3):330-3. French.

7.

Serum ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic cirrhosis: clinical and pathophysiological implications.

Le Lan C, Ropert M, Lainé F, Medevielle M, Jard C, Pouchard M, Le Treut A, Moirand R, Loréal O, Brissot P.

Alcohol Clin Exp Res. 2004 May;28(5):775-9.

PMID:
15166653
8.

Promoter analysis of the human translation termination factor 1 gene.

Dubourg C, Toutain B, Le Gall JY, Le Treut A, Guenet L.

Gene. 2003 Oct 16;316:91-101.

PMID:
14563555
9.

Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.

Dubourg C, Toutain B, Hélias C, Henry C, Lessard M, Le Gall JY, Le Treut A, Guenet L.

Cancer Genet Cytogenet. 2002 Apr 1;134(1):33-7.

PMID:
11996793
10.

Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients.

Lainé F, Ropert M, Lan CL, Loréal O, Bellissant E, Jard C, Pouchard M, Le Treut A, Brissot P.

J Hepatol. 2002 Jan;36(1):60-5.

PMID:
11804665
11.

Don't forget to test for D-lactic acid in short bowel syndrome.

Godey F, Bouasria A, Ropert M, Diakite M, Le Treut A, Balençon M.

Am J Gastroenterol. 2000 Dec;95(12):3675-7. No abstract available.

PMID:
11151936
12.

Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations.

Jézéquel P, Dubourg C, Le Lannou D, Odent S, Le Gall JY, Blayau M, Le Treut A, David V.

Mol Hum Reprod. 2000 Dec;6(12):1063-7.

PMID:
11101688
13.

Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases.

Guenet L, Henry C, Toutain B, Dubourg C, Le Gall JY, David V, Le Treut A.

Cytogenet Cell Genet. 2000;88(1-2):82-6.

PMID:
10773672
14.

In patients with cirrhosis, serum albumin determination should be carried out by immunonephelometry rather than by protein electrophoresis.

Mendler MH, Corbinais S, Sapey T, Lucas-Clerc C, Tiisma V, Guyader D, Deugnier Y, Le Treut A, Brissot P.

Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1405-11.

PMID:
10654802
15.

Human release factor eRF1: structural organisation of the unique functional gene on chromosome 5 and of the three processed pseudogenes.

Guenet L, Toutain B, Guilleret I, Chauvel B, Deaven LL, Longmire JL, Le Gall JY, David V, Le Treut A.

FEBS Lett. 1999 Jul 2;454(1-2):131-6.

16.

Magnetic resonance imaging in the treatment planning of radiation therapy in carcinoma of the cervix treated with the four-field pelvic technique.

Thomas L, Chacon B, Kind M, Lasbareilles O, Muyldermans P, Chemin A, Le Treut A, Pigneux J, Kantor G.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):827-32.

PMID:
9128958
17.

Identification of a novel mutation in CFTR gene exon 8 (L375F) in a CUAVD phenotype.

Jézéquel P, Chauvel B, Le Treut A, Le Gall JY, David V, Le Lannou D, Blayau M.

Hum Genet. 1996 Apr;97(4):548-9. No abstract available.

PMID:
8834261
18.

Identification of a novel mutation (A268G) in exon 8 of the HTR beta gene in a large family with thyroid hormone resistance.

Jézéquel P, Guilhem I, Hespel JP, Le Treut A, Gall JY, Allannic H, Blayau M.

Hum Mutat. 1996;8(4):396. No abstract available.

PMID:
8956060
19.

Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE).

Gandon G, Jouanolle AM, Chauvel B, Mauvieux V, le Treut A, Feingold J, Le Gall JY, David V, Yaouanq J.

Hum Genet. 1996 Jan;97(1):103-13.

PMID:
8557248
20.

Structural analysis of CFTR gene in congenital bilateral absence of vas deferens.

Jézéquel P, Dorval I, Fergelot P, Chauvel B, Le Treut A, Le Gall JY, Le Lannou D, Blayau M.

Clin Chem. 1995 Jun;41(6 Pt 1):833-5.

Supplemental Content

Loading ...
Support Center